Response to Letter: Cost Implications of Reactive Versus Prospective Testing for Dihydropyrimidine Dehydrogenase Deficiency in Patients With Colorectal Cancer: A Single-Institution Experience

Detalles Bibliográficos
Autores principales: O'Farrell, Eoin, Bird, Brian, Murphy, Con
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6876174/
https://www.ncbi.nlm.nih.gov/pubmed/31802992
http://dx.doi.org/10.1177/1559325819887068
_version_ 1783473168731602944
author O'Farrell, Eoin
Bird, Brian
Murphy, Con
author_facet O'Farrell, Eoin
Bird, Brian
Murphy, Con
author_sort O'Farrell, Eoin
collection PubMed
description
format Online
Article
Text
id pubmed-6876174
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-68761742019-12-04 Response to Letter: Cost Implications of Reactive Versus Prospective Testing for Dihydropyrimidine Dehydrogenase Deficiency in Patients With Colorectal Cancer: A Single-Institution Experience O'Farrell, Eoin Bird, Brian Murphy, Con Dose Response Letter to the Editor SAGE Publications 2019-11-22 /pmc/articles/PMC6876174/ /pubmed/31802992 http://dx.doi.org/10.1177/1559325819887068 Text en © The Author(s) 2019 http://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Letter to the Editor
O'Farrell, Eoin
Bird, Brian
Murphy, Con
Response to Letter: Cost Implications of Reactive Versus Prospective Testing for Dihydropyrimidine Dehydrogenase Deficiency in Patients With Colorectal Cancer: A Single-Institution Experience
title Response to Letter: Cost Implications of Reactive Versus Prospective Testing for Dihydropyrimidine Dehydrogenase Deficiency in Patients With Colorectal Cancer: A Single-Institution Experience
title_full Response to Letter: Cost Implications of Reactive Versus Prospective Testing for Dihydropyrimidine Dehydrogenase Deficiency in Patients With Colorectal Cancer: A Single-Institution Experience
title_fullStr Response to Letter: Cost Implications of Reactive Versus Prospective Testing for Dihydropyrimidine Dehydrogenase Deficiency in Patients With Colorectal Cancer: A Single-Institution Experience
title_full_unstemmed Response to Letter: Cost Implications of Reactive Versus Prospective Testing for Dihydropyrimidine Dehydrogenase Deficiency in Patients With Colorectal Cancer: A Single-Institution Experience
title_short Response to Letter: Cost Implications of Reactive Versus Prospective Testing for Dihydropyrimidine Dehydrogenase Deficiency in Patients With Colorectal Cancer: A Single-Institution Experience
title_sort response to letter: cost implications of reactive versus prospective testing for dihydropyrimidine dehydrogenase deficiency in patients with colorectal cancer: a single-institution experience
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6876174/
https://www.ncbi.nlm.nih.gov/pubmed/31802992
http://dx.doi.org/10.1177/1559325819887068
work_keys_str_mv AT ofarrelleoin responsetolettercostimplicationsofreactiveversusprospectivetestingfordihydropyrimidinedehydrogenasedeficiencyinpatientswithcolorectalcancerasingleinstitutionexperience
AT birdbrian responsetolettercostimplicationsofreactiveversusprospectivetestingfordihydropyrimidinedehydrogenasedeficiencyinpatientswithcolorectalcancerasingleinstitutionexperience
AT murphycon responsetolettercostimplicationsofreactiveversusprospectivetestingfordihydropyrimidinedehydrogenasedeficiencyinpatientswithcolorectalcancerasingleinstitutionexperience

Ejemplares similares